Market Tracker

05/04 3:42am ET

United Therapeutics Corp (NASDAQ:UTHR)

110.55
Delayed Data
As of May 03
 +0.36 / +0.33%
Today’s Change
102.50
Today|||52-Week Range
190.13
-29.41%
Year-to-Date

Today’s Trading

Previous close110.19
Today’s open109.68
Day’s range108.51 - 113.00
Volume759,635
Average volume (3 months)783,636
Market cap$4.9B
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+9.28%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.76%
P/E ratio6.3
Price/Sales5.47
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.38-3.79%
OPKOPKO Health Inc-0.12-1.15%
GRFSGrifols SA-0.04-0.25%
NBIXNeurocrine Bioscienc...-1.66-3.55%
Data as of 3:59pm ET, 05/03/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$2.99
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts